Brexit plan reassuring for pharma industry, but uncertainties remain: lawyers

16-07-2018

Brexit plan reassuring for pharma industry, but uncertainties remain: lawyers

andrewlinscott / iStockphoto.com

While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers.


Brexit, white paper, harmonisation, IP protection, IP enforcement, Unified Patent Court, EMA, regulatory, Elkington & Fife, Bristows

LSIPR